Lewis Sanders
Sanders Capital
Sanders Capital Portfolio 13F
Lewis Sanders Holdings Activity
- Portfolio value:
- $8.40B≈ (+$1B≈)
- Previous value:
- $7.28B≈
- # of changes:
- 51
- New positions:
- 3
- Reported for:
- 31 Dec 2013 (Q4)
- Latest filing date:
- 07 Sep 2022
Sanders Capital has disclosed a total of 51 changes to the portfolio in the (2013 Q4) SEC report(s): increased the number of shares of 30, bought 3 totally new, decreased the number of shares of 16 and completely sold out 2 position(s).
What stocks did Lewis Sanders buy in 2013 Q4?
During 2013 Q4 Lewis Sanders has bought 33 securities out of which top 5 purchases (by % change to portfolio) were (MSFT) Microsoft Corp (added shares +4.18%), (INTC) Intel Corp (added shares +4.41%), (C) Citigroup Inc (added shares +5.86%), (JPM) JPMorgan Chase & Co (added shares +11.05%) and (BAC) Bank of America Corp (added shares +9.94%).
In the 2013 Q4 report(s) the following changes have been made to the top investments: (MSFT) Microsoft Corp (added shares +4.18%), (INTC) Intel Corp (added shares +4.41%), (C) Citigroup Inc (added shares +5.86%), (JPM) JPMorgan Chase & Co (added shares +11.05%) and (BAC) Bank of America Corp (added shares +9.94%).
51 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DR Horton Inc
|
new
|
$22.32
|
+571.11%($149.79)
|
0.90%
|
2013 Q4
|
≈ 0.25 years
|
||||
|
|
iShares MSCI EAFE ETF
|
new
|
$67.06
|
+59.90%($107.23)
|
0.41%
|
2013 Q4
|
≈ 0.25 years
|
||||
|
|
RYLAND GROUP INC/THE
|
new
|
$43.41
|
|
0.54%
|
2013 Q4
|
≈ 0.25 years
|
||||
|
|
iShares MSCI Brazil ETF
|
+115.97%
|
$44.68
|
-18.68%($36.33)
|
0.01%
|
2013 Q2 or earlier
|
≈ 0.75+ years
|
||||
|
|
SPDR S&P 500 ETF Trust
|
+39.37%
|
$184.67
|
+318.50%($772.84)
|
1.56%
|
2013 Q2 or earlier
|
≈ 0.75+ years
|
||||
|
|
Shinhan Financial Group Co Ltd
|
+36.60%
|
$45.71
|
+57.30%($71.90)
|
0.07%
|
2013 Q2 or earlier
|
≈ 0.75+ years
|
||||
|
|
Barclays PLC ADR
|
+27.12%
|
$18.13
|
+55.53%($28.20)
|
0.06%
|
2013 Q2 or earlier
|
≈ 0.75+ years
|
||||
|
|
Vanguard FTSE All-World ex-US Index Fund ETF Shares
|
+26.43%
|
$50.73
|
+66.64%($84.54)
|
0.24%
|
2013 Q2 or earlier
|
≈ 0.75+ years
|
||||
|
|
Sanofi ADR
|
+21.92%
|
$53.63
|
-20.26%($42.76)
|
0.04%
|
2013 Q2 or earlier
|
≈ 0.75+ years
|
||||
|
|
JPMorgan Chase & Co
|
+11.05%
|
$58.48
|
+516.22%($360.36)
|
4.63%
|
2013 Q2 or earlier
|
≈ 0.75+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.